I very much welcome my right hon. Friend’s statement. Will he consider issuing separate guidance for business travellers who have multiple short visits abroad? It is self-evident that they cannot take a test three days before returning if they have only a one or two-day visit, so given that many business travellers will undertake such visits, will he issue that guidance? Can he also give a commitment to publish the criteria on which the decision to place a country on the green, amber or red list is taken? If the travel industry knew what the criteria were and the methodology, it would have an idea of the direction of travel rather than having sudden events and deadlines imposed upon it.
My right hon. Friend is absolutely right to mention the case of, for example, a business traveller who might go from A to B to C. One of the things that is little noticed is that a test is up to day 2—it is not a day 2 test per se. It might be helpful, though, if I were to write to him in more detail about the application and how that would work under this new system with regard to, for example, somebody travelling for business to many different places.
Finally, I am pleased to tell him that on the gov.uk website, the methodology for the Joint Biosecurity Centre is already set out. It does include subsections of a number of different criteria that apply. I often hear people say, “X country has fewer cases than we do, so why aren’t they on the green list?” The answer is probably that they are not sequencing their genome, they are not uploading it to the GISAID internationally recognised format, and perhaps they are not vaccinating people at quite the rate that we have. There are many different factors, but they are all set out by the JBC.